Total MarketCap: $0 0
24H Vol: $0.00
BTC:
0 sat/vB
ETH: Gwei
Feedback
EN
Dark

SearchSSI/Mag7/Meme/ETF/Coin/Index/Charts/Research
00:00
00:0000:00
00:00 / 00:00
    Markets
    Indexes
    NewsFeed
    TokenBar®
    Analysis
    Macro
    Watchlist
Enable crypto investment for the global masses
Scan QR Code to Explore more key information
Enable crypto investment for the global masses
AxonDAO
Digital Healthcare Solutions
axondao
Twitter
Medium
LinkedIn
Categories:
Medical health
Infra
Founded:
2021
AxonDAO aims to use blockchain and artificial intelligence to restructure the way humans interact with their own health data. AxonDAO collects medical and health data through DePIN, and uses input methods such as biometrics, genomics data and other key health indicators to form specific AI precognitive algorithms (Precognitive Algorithms) to standardize and tokenize these data. , protocolization to facilitate application to back-end research, new drugs, therapies and diagnostic and treatment services. AxonDAO can not only monitor the individual data itself, but also predict the future health status of the individual.
AxonDAO Team
Maciej Stachowiak
CTO
Christopher Crecelius
Founder & CEO
Tharusha Jayasena
Chief scientific officer
Bo Howell
CLO
Scan QR Code to Explore more key information

AxonDAO Governance Token

AXGT

AxonDAO
Digital Healthcare Solutions
axondao
Twitter
Medium
LinkedIn
Categories:
Medical health
Infra
Founded:
2021
AxonDAO aims to use blockchain and artificial intelligence to restructure the way humans interact with their own health data. AxonDAO collects medical and health data through DePIN, and uses input methods such as biometrics, genomics data and other key health indicators to form specific AI precognitive algorithms (Precognitive Algorithms) to standardize and tokenize these data. , protocolization to facilitate application to back-end research, new drugs, therapies and diagnostic and treatment services. AxonDAO can not only monitor the individual data itself, but also predict the future health status of the individual.
AxonDAO Team
Maciej Stachowiak
CTO
Christopher Crecelius
Founder & CEO
Tharusha Jayasena
Chief scientific officer
Bo Howell
CLO
Powered by
AxonDAO Governance Token
AXGT
Add
$0
-16.55%
Total dollar volume24H
$282,731
High24H
$0.0247
Low24H
$0.02027
Market Cap
#798$9,796,254
FDV
$20,781,564
Market Cap / FDV Ratio
0.47
Turnover rate
2.89%
Circulating supply
471,391,558
Total supply
1,000,000,000
Max supply
1,000,000,000
All time high
$1.0179
All time high date
Mar 18, 2024
Down from All time high
-97.96%
Cycle low
$0.01877
Cycle low date
Nov 21, 2025
Up from cycle low
10.71%
Contracts
Etherscan:0xdd...f21d
Official links
Website
White paper
Socials
Twitter
Telegram
Medium
Discord
Linkedin
Introduction

AxonDAO Governance Token (AXGT) is the native token of AxonDAO, a decentralized organization dedicated to advancing decentralized science (DeSci). AXGT empowers token holders to participate in governance, vote on proposals, and guide the allocation of research funding, thereby decentralizing authority from traditional institutions to individual researchers and the community.

AxonDAO originated as a telemedicine clinical data startup in 2013 and transitioned into a DAO in 2021, marking a significant evolution in its operational model. This transformation underscores a commitment to DeSci, aiming to make scientific research more transparent, secure, and objective.

A notable project within AxonDAO is A+ Voice, which utilizes a biometric precognitive voice AI+ system to facilitate decentralized clinical research. Participants can contribute their voice data to research while retaining full ownership and control, revolutionizing the use of data in scientific advancement.

AxonDAO has achieved significant milestones, including approval into NVIDIA's Inception Program in 2023, providing advanced computing resources for its research initiatives. The organization has also gained recognition within the DeSci community, receiving support in two rounds of Gitcoin funding and acknowledgment through the Polygon DeSci Voucher.

Looking ahead, AxonDAO's roadmap includes pioneering research in areas such as microdosing protocols, PTSD studies for first responders and veterans, biometric research on dementia and Alzheimer's disease, ultrasound therapy, and psychedelic therapy clinical trials. Through these efforts, AxonDAO continues to push the boundaries of decentralized science, ensuring research remains accessible, ethical, and driven by a global community.

TermsPrivacy PolicyWhitePaperOfficial VerificationSoDEXSSICookieBlogSupport
sha512-hG5LNIIthHjB3nK40JgfgnAkh7g3OACyi7a0BAxuXEajMh+LUDkqWm/IyfVLvWSX0yQg1kcgrssI94UoMhTgWQ==
sha512-kYWj302xPe4RCV/dCeCy7bQu1jhBWhkeFeDJid4V8+5qSzhayXq80dsq8c+0s7YFQKiUUIWvHNzduvFJAPANWA==